Evidence map›Paper›PMID 40877221›Full record

ReviewCell death discovery2025

The role and clinical value of natriuretic peptide receptor family in malignant tumor.

Chuqi Quan, Weilin Shao, Yihao Yang, Qian Yao, Zuozhang Yang, Zhihong Yao

Abstract readReview
In one paragraph

Review in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuqi Quan *Cancer Research Institute of Yunnan Province, Peking University Cancer Hospital Yunnan,Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Weilin Shao *Cancer Research Institute of Yunnan Province, Peking University Cancer Hospital Yunnan,Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Yihao YangBone and Soft Tissue Tumors Research Centre of Yunnan Province, Department of Orthopaedics, Peking University Cancer Hospital Yunnan,Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Qian YaoCancer Research Institute of Yunnan Province, Peking University Cancer Hospital Yunnan,Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zuozhang YangBone and Soft Tissue Tumors Research Centre of Yunnan Province, Department of Orthopaedics, Peking University Cancer Hospital Yunnan,Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. yangzuo-zhang@kmmu.edu.cn.
Zhihong YaoCancer Research Institute of Yunnan Province, Peking University Cancer Hospital Yunnan,Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. yaozhihong@kmmu.edu.cn.ORCID http://orcid.org/0000-0003-2616-9704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natriuretic peptide receptor (NPR) family (NPRA, NPRB, NPRC) regulates diverse physiological and pathological processes. Mounting evidence implicates NPRs as key regulators of oncogenesis, metastasis, and therapy resistance in multiple cancers. This review integrates current understanding of the distinct mechanisms by which NPR members contribute to cancer development and progression, explores their molecular underpinnings, and discusses translational potential and future directions. A central focus is the context-dependent functional duality of NPR signaling, where specific subtypes act as either oncogenic drivers or tumor suppressors depending on the malignancy.

Identifiers

PMID40877221
PMCPMC12394403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.